Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-24

Clinical Trial Update: Reduction of Intravenous Antibiotics In Neonates [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating reduction of intravenous antibiotics in Neonatal Infection and Neonatal Sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Franciscus Gasthuis | Conditions: Neonatal Infection, Neonatal SEPSIS | Phase 4 | Status: COMPLETED